意大利研究人员针对儿童肥胖症这一全球健康挑战，系统评估了当前药物疗法的临床价值与局限性。研究表明，胰高血糖素样肽-1(GLP-1)受体激动剂semaglutide和liraglutide在青少年群体中展现出显著减重效果，但存在胃肠道不良反应、停药反弹风险及治疗成本等问题。

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

The glucagon-like peptide-1 (GLP-1) analogues liraglutide and semaglutide are approved by the Food and Drug Administration and the European Medicines Agency for long-term weight management in ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study.

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Liraglutide and Semaglutide Market Research Report 2024: Market to Reach $51.83 Billion by 2034 from $15.87 Billion in 2023 - ResearchAndMarkets.com March 11, 2025 03:19 PM Eastern Daylight Time ...

New research reveals that liraglutide, a GLP-1 receptor agonist, crosses the blood-brain barrier to target specific neurons, reducing appetite and promoting lasting weight loss. Liraglutide, a ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...

Study: One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice.Image Credit: Pixel-Shot / Shutterstock.com. A recent JAMA Network Open study compares the weight loss ...